Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis.
HLA-DRB1*15:01 and multiple sclerosis: a female association?
The relevance of animal models in multiple sclerosis research.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
GlaxoSmithKline Protocol Summaries: Firategrast
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
Testosterone treatment in multiple sclerosis: a pilot study.
Sex ratio of multiple sclerosis and clinical phenotype.
National MS Society: Sylvia Lawry Physician Fellowships
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
T(H)17 cytokines in autoimmune neuro-inflammation.
The natural history of primary progressive MS in British Columbia, Canada.
Clinically isolated syndrome - Rethinking the diagnosis.
Episode 39 with Dr. Joseph Berger on diagnostic dilemmas in MS
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Keystone Symposium: Neuroepigenetics
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Environmental, modifiable risk factors for multiple sclerosis
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Episode 23 with Professor Aksel Siva discussing radiologically isolated syndrome (RIS)
Cognitive Test Analysis May Determine Reliable MS Change Over Time

Pages